December 2007
Small Cap Network - Cleaning House For 2008
December 20, 2007
The end of the year is right around the corner, and I for one am glad. We've been itching to close the books on a handful of our followings, and perhaps benefit from a tax loss (since they didn't benefit us in many other ways). At the same time, there are also a few names we want to be sure to keep...
The end of the year is right around the corner, and I for one am glad. We've been itching to close the books on a handful of our followings, and perhaps benefit from a tax loss (since they didn't benefit us in many other ways). At the same time, there are also a few names we want to be sure to keep...
October 2007
Stockgroup Sets Date, Titan Settles With AT&T
October 16, 2007
Not a bad start for Applied DNA (OTCBB: APDN), huh? Up 29.1% on the highest volume day in over a year. What I like best is how well-paced the rally was. I was pretty worried about a wildly strong open, which often sets up nothing but profit-taking later in the day...a tough thing to overcome. In yesterday's...
Not a bad start for Applied DNA (OTCBB: APDN), huh? Up 29.1% on the highest volume day in over a year. What I like best is how well-paced the rally was. I was pretty worried about a wildly strong open, which often sets up nothing but profit-taking later in the day...a tough thing to overcome. In yesterday's...
The Pickle Progresses, MIVT On The Verge
October 10, 2007
I came very close to publishing this newsletter last night rather than this afternoon. But, after thinking it over, I decided I'd rather see how things started out today before highlighting the charts I believe are worth a closer look. Why? While overall I believe the economy is well poised to encourage...
I came very close to publishing this newsletter last night rather than this afternoon. But, after thinking it over, I decided I'd rather see how things started out today before highlighting the charts I believe are worth a closer look. Why? While overall I believe the economy is well poised to encourage...
July 2007
MIV Therapeutics - A Look Ahead, + Q&A's
July 14, 2007
In case you weren't able to participate in MIV Therapeutics' (OTCBB: MIVT) conference call on Friday, we've got a quick recap for you today. Parts of the discussion were stuff we already knew, but we added some new layers of detail with the Q&A session.....as usual. We'll go over the key questions...
In case you weren't able to participate in MIV Therapeutics' (OTCBB: MIVT) conference call on Friday, we've got a quick recap for you today. Parts of the discussion were stuff we already knew, but we added some new layers of detail with the Q&A session.....as usual. We'll go over the key questions...
June 2007
MIVT: The End of the Beginning
June 01, 2007
As hard as some of us might try to make investing a complicated matter, sometimes I really think the wise investment move is just to take things at face value. That's what I thought of when I read last night's news from MIV Therapeutics (OTCBB: MIVT) anyway....the news is what it is. No angles, no fine...
As hard as some of us might try to make investing a complicated matter, sometimes I really think the wise investment move is just to take things at face value. That's what I thought of when I read last night's news from MIV Therapeutics (OTCBB: MIVT) anyway....the news is what it is. No angles, no fine...
April 2007
A Handful of Looming Breakouts
April 29, 2007
Something a little different today. After Wednesday's look at the likely summertime strength in small caps, I thought it would be fitting to study which of our profiled companies seemed technically best-poised to take advantage of the tendency. After all, not every stock can go higher - I've always tried...
Something a little different today. After Wednesday's look at the likely summertime strength in small caps, I thought it would be fitting to study which of our profiled companies seemed technically best-poised to take advantage of the tendency. After all, not every stock can go higher - I've always tried...
Feature Edition: A Biotech Trading Idea
April 07, 2007
The Small Cap Network Newsletter has been on a tear recently, finding a couple of big winners that have yielded significant short-term gains. Stockgroup (OTCBB: SWEB) is up 70% since we first suggested it in late January, while Challenger Powerboats (OTCBB: CPWB) is more than 100% higher than where we...
The Small Cap Network Newsletter has been on a tear recently, finding a couple of big winners that have yielded significant short-term gains. Stockgroup (OTCBB: SWEB) is up 70% since we first suggested it in late January, while Challenger Powerboats (OTCBB: CPWB) is more than 100% higher than where we...
July 2006
A Tiny Medical Device, But a Huge Medical Impact
July 06, 2006
If you asked anyone what the ultimate goal of technology is, they'd probably answer to make life better, easier, or safer. And in many respects, they'd be right. The same goes for biotechnology - the industry has exploded over the last several years because biotech companies are able to perform research...
If you asked anyone what the ultimate goal of technology is, they'd probably answer to make life better, easier, or safer. And in many respects, they'd be right. The same goes for biotechnology - the industry has exploded over the last several years because biotech companies are able to perform research...
December 2005
Feature: 2005 in Review - Beauties and the Beasts.
December 21, 2005
Feature: 2005 in Review - Beauties and the Beasts. I’m not going to belabor the fact that the Santa rally hasn’t materialized for the smallcaps this year. As a matter of fact, the fall pretty much sucked out loud for the genre. Along with some good wins, along with everyone else, we also took some lumps...
Feature: 2005 in Review - Beauties and the Beasts. I’m not going to belabor the fact that the Santa rally hasn’t materialized for the smallcaps this year. As a matter of fact, the fall pretty much sucked out loud for the genre. Along with some good wins, along with everyone else, we also took some lumps...
September 2005
Feature: Katrina Crisis. The Economy. The Market.
September 02, 2005
Feature: Katrina Crisis. The Economy. The Market. As devastating and disturbing as the situation in the US Gulf area becomes, it will in our opinion, have limited long-term economic effect. I suggest that within a month, this unprecedented natural disaster will fade from the headlines, other than being...
Feature: Katrina Crisis. The Economy. The Market. As devastating and disturbing as the situation in the US Gulf area becomes, it will in our opinion, have limited long-term economic effect. I suggest that within a month, this unprecedented natural disaster will fade from the headlines, other than being...
August 2005
Feature: MIV Therapeutics - Impressive Rally. More Patents Filed.
August 30, 2005
Feature: MIV Therapeutics - Impressive Rise. More Patents Filed. In March 2005, we were already convinced of the potential for biotech and medical device company MIV Therapeutics (OTCBB: MIVT) when we Alerted the readership to the shares at 34 cents. However, even to our typically cynical eyes, the...
Feature: MIV Therapeutics - Impressive Rise. More Patents Filed. In March 2005, we were already convinced of the potential for biotech and medical device company MIV Therapeutics (OTCBB: MIVT) when we Alerted the readership to the shares at 34 cents. However, even to our typically cynical eyes, the...
Feature: MIV Therapeutics: New High - Partial Sales Look Prudent.
August 23, 2005
Feature: MIV Therapeutics: New High - Partial Sale Looks Prudent. On June 14th, we did a piece on the coming boom in the biotech market. The Amex Biotech Index (AMEX: ^BTK) was then about 540. It’s now 613. We also featured the NASDAQ Biotech Index iShares (AMEX: IBB) at $65. They’re now $74.50. But...
Feature: MIV Therapeutics: New High - Partial Sale Looks Prudent. On June 14th, we did a piece on the coming boom in the biotech market. The Amex Biotech Index (AMEX: ^BTK) was then about 540. It’s now 613. We also featured the NASDAQ Biotech Index iShares (AMEX: IBB) at $65. They’re now $74.50. But...
June 2005
Feature: Once Around the Stable - Biophan, Biocurex et al...
June 22, 2005
Feature: Once Around the Stable - Biophan, BioCurex et al… Received some great emails on our educational/big cap strategy pieces over the last week. We like to mix it up a bit so if you have any market topics you’d like to see us cover—no matter how basic you may think they are-- send ‘em in here. Or...
Feature: Once Around the Stable - Biophan, BioCurex et al… Received some great emails on our educational/big cap strategy pieces over the last week. We like to mix it up a bit so if you have any market topics you’d like to see us cover—no matter how basic you may think they are-- send ‘em in here. Or...
Feature: Biotech - The Next Big Boom?
June 14, 2005
Feature: Biotech - The Next Big Boom? For the most part, Biotech companies don’t trade on fundamentals. They are trade on the three ‘P’s”: potential, pipeline and vision. OK, two p’s and a v. Even senior companies’ prices--such as Genentech (NYSE: DNA) --look positively goofy if you try to rationalize...
Feature: Biotech - The Next Big Boom? For the most part, Biotech companies don’t trade on fundamentals. They are trade on the three ‘P’s”: potential, pipeline and vision. OK, two p’s and a v. Even senior companies’ prices--such as Genentech (NYSE: DNA) --look positively goofy if you try to rationalize...
Feature: Bio Advances - Biophan, MIV Therapeutics. Stream's Revenue
June 07, 2005
Feature: Bio Advances - Biophan, MIV Therapeutics. Stream's Revenue Flows. Biophan (OTCBB: BIPH) CEO Michael Weiner recently stated: “There is no longer any excuse for not making and certifying devices to be safe with MRI machines.” And he should know. Biophan now holds 127 issued or pending US patents...
Feature: Bio Advances - Biophan, MIV Therapeutics. Stream's Revenue Flows. Biophan (OTCBB: BIPH) CEO Michael Weiner recently stated: “There is no longer any excuse for not making and certifying devices to be safe with MRI machines.” And he should know. Biophan now holds 127 issued or pending US patents...
May 2005
Feature: MIV Therapeutics - Implanting Life Saving Solutions.
May 23, 2005
Feature: MIV Therapeutics - Implanting Life Saving Solutions. Heart disease is, unfortunately, a growth industry, Three percent of baby boomers currently have heart disease and that number is expected to grow 10-15 percent within that demographic over the next 10 years. That’s more than 500,000 new...
Feature: MIV Therapeutics - Implanting Life Saving Solutions. Heart disease is, unfortunately, a growth industry, Three percent of baby boomers currently have heart disease and that number is expected to grow 10-15 percent within that demographic over the next 10 years. That’s more than 500,000 new...
Feature: MIV Therapeutics - Stalking a Killer.
May 13, 2005
Feature: MIV Therapeutics - Stalking a killer. Strokes are the third leading cause of death and THE leading cause of disability. That fact alone, in our opinion, makes the work and investment potential of MIV Therapeutics (OTCBB: MIVT) even more compelling. Technological improvements and advancements...
Feature: MIV Therapeutics - Stalking a killer. Strokes are the third leading cause of death and THE leading cause of disability. That fact alone, in our opinion, makes the work and investment potential of MIV Therapeutics (OTCBB: MIVT) even more compelling. Technological improvements and advancements...
April 2005
Feature: MIV Therapeutics - The Life They Save...
April 21, 2005
Feature: MIV Therapeutics - The Life They Save… Before we chat about MIV Therapeutics (OTCBB: MIVT) and the amazing progress the company has made on its rapid journey towards commercialization, an important word about the SCBLOG—our complimentary real-time publication that delivers critical information...
Feature: MIV Therapeutics - The Life They Save… Before we chat about MIV Therapeutics (OTCBB: MIVT) and the amazing progress the company has made on its rapid journey towards commercialization, an important word about the SCBLOG—our complimentary real-time publication that delivers critical information...
Feature: MIV Validates Biocompatibility. Xtreme Floats More Boats.
April 18, 2005
Feature: MIV Validates Biocompatibility. Xtreme Floats More Boats. MIV Therapeutics (OTCBB: MIVT) issued two significant press releases late last week regarding product studies that markedly advance the importance of both its technologies as well as move it closer toward its goal of commercialization...
Feature: MIV Validates Biocompatibility. Xtreme Floats More Boats. MIV Therapeutics (OTCBB: MIVT) issued two significant press releases late last week regarding product studies that markedly advance the importance of both its technologies as well as move it closer toward its goal of commercialization...
Feature: MIV Therapeutics - Advancing Cardiac Devices. Big Time.
April 07, 2005
Feature: MIV Therapeutics - Advancing Cardiac Devices. Big Time. MIV Therapeutic's (OTCBB: MIVT) R&D continues to deliver the goods. Thursday's release (below) details two new patents filed by the company that build on the promise of making cardiac stents and indeed a number of implantable devices...
Feature: MIV Therapeutics - Advancing Cardiac Devices. Big Time. MIV Therapeutic's (OTCBB: MIVT) R&D continues to deliver the goods. Thursday's release (below) details two new patents filed by the company that build on the promise of making cardiac stents and indeed a number of implantable devices...
March 2005
Feature: A Stock In Play? More SmallCap Business Intelligence.
March 23, 2005
Feature: A Stock In Play? More SmallCap Business Intelligence. As a result of recent acquisitions and consolidations, data integrator Informatica Corp (NASDAQ: INFA) appears pretty much the only game left in town in the growing business intelligence sector. Press articles are printing rumors that this...
Feature: A Stock In Play? More SmallCap Business Intelligence. As a result of recent acquisitions and consolidations, data integrator Informatica Corp (NASDAQ: INFA) appears pretty much the only game left in town in the growing business intelligence sector. Press articles are printing rumors that this...
Feature: MIV Therapeutics - A Stroke Stopping Acquisition.
March 19, 2005
Feature: MIV Therapeutics - A Stroke Stopping Acquisition. We don’t usually publish two pieces on the same company within a week, however, substantive news can trump that practice. And this news is certainly applicable. We Alerted the readership to MIV Therapeutics (OTCBB: MIVT) last Friday with the...
Feature: MIV Therapeutics - A Stroke Stopping Acquisition. We don’t usually publish two pieces on the same company within a week, however, substantive news can trump that practice. And this news is certainly applicable. We Alerted the readership to MIV Therapeutics (OTCBB: MIVT) last Friday with the...
Trading Alert: MIV Therapeutics - Superior Stents. Global Deal.
March 12, 2005
Trading Alert: MIV Therapeutics - Superior Stents. Global Deal. A few years ago, investors likely hadn’t even heard of cardiac stents. And until now, they’d likely not heard of MIV Therapeutics (OTCBB: MIVT), either. We believe this smallcap company not only has the biotechnology to eventually gain...
Trading Alert: MIV Therapeutics - Superior Stents. Global Deal. A few years ago, investors likely hadn’t even heard of cardiac stents. And until now, they’d likely not heard of MIV Therapeutics (OTCBB: MIVT), either. We believe this smallcap company not only has the biotechnology to eventually gain...
